FY2024 EPS Estimates for Fresenius SE & Co. KGaA Lowered by Analyst (OTCMKTS:FSNUY)

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY – Get Rating) – Analysts at Jefferies Financial Group cut their FY2024 earnings per share estimates for shares of Fresenius SE & Co. KGaA in a research note issued on Tuesday, March 14th. Jefferies Financial Group analyst J. Vane-Tempest now anticipates that the company will post earnings of $0.79 per share for the year, down from their prior estimate of $1.02. Jefferies Financial Group currently has a “Buy” rating on the stock. The consensus estimate for Fresenius SE & Co. KGaA’s current full-year earnings is $0.78 per share.

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY – Get Rating) last posted its quarterly earnings results on Tuesday, February 21st. The company reported $0.20 EPS for the quarter. Fresenius SE & Co. KGaA had a return on equity of 5.19% and a net margin of 3.50%. The company had revenue of $10.87 billion during the quarter.

A number of other equities research analysts have also weighed in on the company. UBS Group upgraded Fresenius SE & Co. KGaA from a “neutral” rating to a “buy” rating in a research report on Monday, November 28th. Citigroup started coverage on Fresenius SE & Co. KGaA in a research report on Monday, December 12th. They set a “buy” rating on the stock. Three equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $31.40.

Fresenius SE & Co. KGaA Price Performance

Fresenius SE & Co. KGaA stock opened at $6.27 on Thursday. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.99 and a current ratio of 1.32. Fresenius SE & Co. KGaA has a 52 week low of $4.79 and a 52 week high of $9.71. The stock has a market capitalization of $14.01 billion, a P/E ratio of 9.36 and a beta of 1.10. The stock has a fifty day moving average of $7.18 and a 200-day moving average of $6.51.

About Fresenius SE & Co. KGaA

(Get Rating)

Fresenius SE & Co KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed. The Fresenius Medical Care segment caters to individuals with renal diseases.